SHL Telemedicine Discloses 2024 Write-Offs and Extraordinary Items
Ticker: SHMLF · Form: 6-K · Filed: Apr 3, 2025 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, write-offs, extraordinary-items
TL;DR
SHL Telemedicine flags write-offs and extraordinary items for 2024 results.
AI Summary
On April 3, 2025, SHL Telemedicine Ltd. announced write-offs and extraordinary items impacting its full-year 2024 results. The company issued a press release detailing these financial adjustments, which are incorporated into this Form 6-K filing.
Why It Matters
This filing provides crucial information about the financial health and performance of SHL Telemedicine Ltd. for the fiscal year 2024, potentially affecting investor decisions.
Risk Assessment
Risk Level: medium — The disclosure of write-offs and extraordinary items suggests potential financial challenges or significant one-time events that could impact the company's profitability and future outlook.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- April 3, 2025 (date) — Date of press release and filing
- 2024 (date) — Fiscal year for which results are being reported
FAQ
What specific write-offs and extraordinary items are disclosed by SHL Telemedicine Ltd. for the full year 2024?
The filing states that a press release titled 'SHL discloses write-offs and extraordinary items for full year results 2024' was issued on April 3, 2025, and is attached as Exhibit 99.1. Specific details of these items would be found within that press release.
When was the press release regarding the 2024 results filed?
The press release was issued on April 3, 2025, and is attached to the Form 6-K filed on the same date.
What is the primary purpose of this Form 6-K filing?
This Form 6-K filing serves as a Report of Foreign Private Issuer, providing information to the SEC, specifically by attaching a press release detailing SHL Telemedicine Ltd.'s full-year 2024 results, including write-offs and extraordinary items.
Does SHL Telemedicine Ltd. file annual reports under Form 20-F or Form 40-F?
SHL Telemedicine Ltd. indicates that it files annual reports under Form 20-F.
Where is SHL Telemedicine Ltd. headquartered?
SHL Telemedicine Ltd. is headquartered at 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 3, 2025 regarding SHL TELEMEDICINE LTD (SHMLF).